.

Saturday, June 8, 2019

Case study Example | Topics and Well Written Essays - 500 words - 103

Case Study ExampleWhile Genzymes focus on orphan drugs feces be questioned, on the face of it, this decision was a pragmatic one as is also substantiated by the tangible success of the follow. Owing to its production of drugs for grand diseases it was easier for the company to target its markets, although essentially smaller than those for the widely-needed drugs, more systematically and sustainably. Moreover its focus on orphan drugs also made it possible for the company to increase full benefits of tax breaks and market exclusivity contained in the Orphan Drug Act introduced by FDA in 1983 thus multiplying the chances of Genzymes domination of the already-limited orphan drugs market.As furthest as the strategic intent of Genzyme is concerned the company its a long term one as is being depicted by the companys variegation of the drugs it produces. In numberition to its focus on orphan drugs it is also producing common drugs so as to secure its share of the bigger markets simi larly which can ensure accruing continued profit by the company and hence further cement its position in the pharmaceutical patience.Although Genzyme is actively pursuing diversification of its market through production of common drugs too the company should retain its focus on orphan drugs as the incidence of rare diseases such as certain kidney disorders and forms of cancer, whose cure is offered by the orphan drugs, is continually on the rise. Moreover, as the companys exemplary success testifies to the latent practicality of its decision of focusing on orphan drugs it should take steps towards further specialized areas of medicine and medical technology so as to sustain its distinct position in the industry rather than plunging into the arena of common medicine characterized by fierce competition.Moreover if the company works towards integration of modern medical technology with its products it can add to the breadth of its market further. In

No comments:

Post a Comment